Cite Filings / FULC / 0000070858-26-000396
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

Fulcrum Therapeutics, Inc. · Filed 2026-08-03 · Acc 0000070858-26-000396

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-08-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-08-10 8-K Executive or director change
  • 2026-08-03 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-07-30 10-Q Quarterly Report
  • 2026-07-28 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-07-17 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · ADAR1 Capital Management, LLC 8.7%
  2. 2026-11-16 SCHEDULE 13G/A · EcoR1 Capital, LLC 8.9%
  3. 2026-11-13 SCHEDULE 13G/A · Nantahala Capital Management, LLC 8.62%
  4. 2026-11-13 SCHEDULE 13G/A · Montanova Capital, LLC 0%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…